Rakovina Therapeutics Unveils Preclinical Data at the AACR - World's Premier Cancer Research Forum

VANCOUVER, British Columbia, March 25, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO), a biopharmaceutical company advancing innovative cancer therapies through artificial intelligence (AI)-powered drug discovery, today announced that two of its abstracts have been accepted for presentation at the upcoming 2025 American Association for Cancer Research (AACR) Annual Meeting, taking place April 25–30 in Chicago, Illinois. The AACR Annual Meeting is widely considered the most prest ...